CHASE AORTIC PERFUSION CANNULA

CHASE AORTIC PERFUSION CANNULA is an FDA 510(k)-cleared medical device (K970914) manufactured by Chase Medical, Inc.. This device is classified under the Cardiovascular specialty. FDA Device Class II (Special Controls) — moderate risk, requires 510(k) clearance. FDA clearance granted on May 12, 1997. Regulation: 8.